Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10117945 mTORC1 inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 10, 2017
Date of Patent
November 6, 2018
Patent Application Number
15455727
Patent Citations Received
‌
US Patent 12121522 Methods of treating cancer with an mTOR inhibitor
0
‌
US Patent 10980889 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
‌
US Patent 11685749 C26-linked rapamycin analogs as mTOR inhibitors
0
‌
US Patent 11364300 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
‌
US Patent 11819476 Rapamycin analogs and uses thereof
0
‌
US Patent 10646577 mTORC1 inhibitors
‌
US Patent 10683308 Rapamycin analogs and uses thereof
Patent Inventor Names
Kevan Shokat
0
Masanori Okaniwa
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10117945
Patent Primary Examiner
‌
Bruck Kifle

Find more entities like US Patent 10117945 mTORC1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.